Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SAR441344
DRUG
2 trials
Sponsors
Sanofi
Conditions
Healthy Volunteers
Sjogren's Syndrome
Sjögren's Syndrome
Phase 1
Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects
Completed
NCT05845996
Sanofi
Healthy Volunteers
Start: 2018-11-08
End: 2020-04-10
Updated: 2025-09-16
Phase 2
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
Completed
NCT04572841
Sanofi
Sjogren's Syndrome, Sjögren's Syndrome
Start: 2020-11-12
End: 2024-02-09
Updated: 2025-10-09